By | February 12 2010 5:27 AM

Biopharmaceutical company Athersys Inc. yesterday announced the addition of two patents to its broad intellectual property portfolio, now consisting of 14 granted patents and more than 120 global patent applications around its stem cell technology and MultiStem product platform.